Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | PARP1 | P09874 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 2/20 | 0.46 |
| ▸ | DAO | P14920 | 1/20 | 0.46 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11589556 | 0.87 | TDP1 (0.46) | TDP1L3MBTL1TSHRCYP2C19POLB | |
| SCHEMBL27645357 | 0.87 | TDP1 (0.46) | TDP1L3MBTL1TSHRCYP2C19POLB | |
| SCHEMBL9284893 | 0.85 | F7 (0.59) | TDP1TSHRCYP3A4ALDH1A1GAA | |
| SCHEMBL1574223 | 0.85 | CES1 (0.55) | TDP1L3MBTL1TSHRCYP2C19POLB | |
| SCHEMBL9284891 | 0.84 | KMT2A (0.56) | L3MBTL1TSHRMAPTHSD17B10ALDH1A1 | |
| SCHEMBL13377799 | 0.82 | AKT1 (0.47) | TDP1L3MBTL1TSHRCYP2C19POLB | |
| SCHEMBL28757765 | 0.82 | ALDH1A1 (0.46) | TDP1L3MBTL1TSHRCYP2C19POLB | |
| SCHEMBL28939211 | 0.82 | CYP2C19 (0.50) | TDP1L3MBTL1TSHRCYP2C19POLB | |
| SCHEMBL6933107 | 0.82 | BLM (0.50) | TDP1L3MBTL1TSHRCYP2C19POLB | |
| SCHEMBL6267389 | 0.82 | TSHR (0.50) | TDP1L3MBTL1TSHRCYP2C19POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104710491-A | Preparation method for (2'R)-2'-deoxy-2'-fluoro-2'-methyluridine | NINGBO CHEMGOO PHARMACEUTICAL TECHNOLOGY INNOVATION LTD | 2015-06-17 | — | — | CN | claimed |
| US-6946554-B2 | Process for the preparation of 9-deazaguanine derivatives | BIOCRYST PHARMACEUTICALS, INC. (US) | 2005-09-20 | — | — | US | claimed |
| US-20040254181-A1 | Process for the preparation of 9-deazaguanine derivatives | BIOCRYST PHARMACEUTICALS, INC. | 2004-12-16 | — | — | US | claimed |
| CN-122080093-A | Compounds effective in treating liver toxicity and fatty liver disease and uses thereof | — | 2026-05-26 | — | — | CN | disclosed |
| US-20250382514-A1 | CURABLE ADHESIVE COMPOSITION COMPRISING MALEIMIDE AND THIOL | HENKEL AG & CO KGAA (DE) | 2025-12-18 | — | — | US | disclosed |
| US-12460043-B2 | Epoxy resin composition for fiber-reinforced composite material, prepreg, and fiber-reinforced composite material | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2025-11-04 | — | — | US | disclosed |
| EP-4282902-B1 | RESIN COMPOSITION, CURED PRODUCT, SEALING MATERIAL, ADHESIVE, INSULATING MATERIAL, COATING MATERIAL, PREPREG, MULTILAYERED BODY, AND FIBER-REINFORCED COMPOSITE MATERIAL | MITSUBISHI GAS CHEMICAL CO (JP) | 2025-07-02 | — | — | EP | disclosed |
| CN-119365518-A | Resin composition, cured product, sealing material, adhesive, insulating material, coating material, prepreg, multilayer body, and fiber-reinforced composite material | 三菱瓦斯化学株式会社 | 2025-01-24 | — | — | CN | disclosed |
| EP-4392998-A1 | ELECTRICALLY CONDUCTIVE ADHESIVE COMPOSITION FOR BONDING SOLAR CELLS | Henkel AG & Co. KGaA (DE) | 2024-07-03 | — | — | EP | disclosed |
| US-20240199925-A1 | ELECTRICALLY CONDUCTIVE ADHESIVE COMPOSITION FOR BONDING SOLAR CELLS | HENKEL AG & CO KGAA (DE) | 2024-06-20 | — | — | US | disclosed |
| US-20240124621-A1 | CURABLE COMPOSITION AND USE THEREOF | HENKEL AG & CO KGAA (DE) | 2024-04-18 | — | — | US | disclosed |
| US-6946554-B2 | Process for the preparation of 9-deazaguanine derivatives | BIOCRYST PHARMACEUTICALS, INC. (US) | 2005-09-20 | — | — | US | disclosed |
| US-20040254181-A1 | Process for the preparation of 9-deazaguanine derivatives | BIOCRYST PHARMACEUTICALS, INC. | 2004-12-16 | — | — | US | disclosed |
| US-6303264-B1 | PROFILE OF PATTERN OF QUARTER MICRON ORDER WITHOUT CAUSING FOOTING, WHILE RETAINING HIGH RESOLUTION ABILITY AND HIGH SENSITIVITY | WAKO PURE CHEMICAL INDUSTRIES, LTD (JP) | 2001-10-16 | — | — | US | disclosed |
| US-6180250-B1 | EPOXY RESIN OBTAINED BY GLYCIDYL ETHERIFYING A CONDENSATION PRODUCT OF A PHENOL AND HYDROXYBENZALDEHYDE; CONDENSATION PRODUCT OF BISPHENOL A AND FORMALDEHYDE; AND A UREA DERIVATIVE. | HITACHI CHEMICAL CO., LTD. (JP) | 2001-01-30 | — | — | US | disclosed |
| EP-0970029-A1 | PROCESS FOR THE PREPARATION OF 9-DEAZAGUANINE DERIVATIVES | BIOCRYST PHARMACEUTICALS INC. (US) | 2000-01-12 | — | — | EP | disclosed |
| EP-0875787-A1 | Method for reducing the substrate dependence of resist | Wako Pure Chemical Industries, Ltd. (JP) | 1998-11-04 | — | — | EP | disclosed |
| EP-0870805-A2 | Epoxy composition for printed circuit boards | Hitachi Chemical Co., Ltd. (JP) | 1998-10-14 | — | — | EP | disclosed |
| WO-1997021653-A1 | PROCESS FOR THE PREPARATION OF 9-DEAZAGUANINE DERIVATIVES | BIOCRYST PHARMACEUTICALS, INC. (US) | 1997-06-19 | — | — | WO | disclosed |
| US-5308743-A | USED IN THE MANUFACTURE OF SEMICONDUCTORS AND ELECTRONIC DEVICES | FUJI PHOTO FILM CO., LTD. (JP) | 1994-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254181-A1 | Process for the preparation of 9-deazaguanine derivatives | ALKBH3, ALKBH2, ALKBH1 | TDP1 646/4885L3MBTL1 4370/4885TSHR 2338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.